Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Rissling

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Chemical Immunology|June 14, 2000
CD38 in hematopoietic malignanciesM Konopleva, I Rissling, M Andreeff
European Journal of Neurology|May 20, 2008
The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson's diseaseJ C Möller, I Rissling, V Mylius, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Chemical Immunology|June 14, 2000
CD38 in hematopoietic malignanciesM Konopleva, I Rissling, M Andreeff
European Journal of Neurology|May 20, 2008
The prevalence of the G2019S and R1441C/G/H mutations in LRRK2 in German patients with Parkinson's diseaseJ C Möller, I Rissling, V Mylius, et al.
Pageof 1